,
your personalized virtual assistant to find clinical trials. Go head, 
Janet C. Ruzich
Providence Milwaukie HospitalMilwaukie, Oregon - 97222 (503-513-8300) |
- CLINICAL TRIALS 31
- CONDITIONS47
- INTERVENTIONS82
- SINCE1989
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
April 2008 - June 2011
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer
July 2008 - August 2009
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
June 2007 - April 2012
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
July 2009 - February 2012
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
May 2010 - May 2011
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
March 2005 - June 2015
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011
Dinaciclib in Treating Patients With Stage IV Melanoma
July 2009 - May 2010
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -
Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
February 1989 -
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
March 1993 -
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
December 2008 - January 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
November 2008 - August 2009
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009
Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
December 2008 - December 2010
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Everolimus Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
March 2009 - September 2009
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Urinary Bladder Neoplasms
Kidney Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Melanoma
Glioblastoma
Carcinoma, Small Cell
Precancerous Conditions
Hodgkin Disease
Myeloproliferative Disorders
Colorectal Neoplasms
Carcinoma, Transitional Cell
Lymphoma, Large-Cell, Immunoblastic
Neuroendocrine Tumors
Hematologic Neoplasms
Cholangiocarcinoma
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Waldenstrom Macroglobulinemia
Carcinoma, Ductal, Breast
Gallbladder Neoplasms
Bile Duct Neoplasms
Ureteral Neoplasms
Carcinoma, Ductal
Urologic Neoplasms
Carcinoma, Neuroendocrine
Monoclonal Gammopathies, Benign
Paraproteinemias
Urethral Neoplasms
Placebo
Intensity-Modulated Radiation Therapy
Computed Tomography
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Liquid Chromatography
Filgrastim
Study Of Socioeconomic And Demographic Variables
Aflibercept
Pharmacological Study
Fludeoxyglucose F 18
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Temozolomide
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Bortezomib
Dexamethasone
Polymerase Chain Reaction
Sunitinib Malate
Vinblastine Sulfate
Mass Spectrometry
Everolimus
Trastuzumab
Lapatinib Ditosylate
Cixutumumab
Thalidomide
Fluorescence In Situ Hybridization
Azacitidine
Mutation Analysis
Cetuximab
Biologic Sample Preservation Procedure
3'-Deoxy-3'-[18f]Fluorothymidine
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Tamoxifen Citrate
Irinotecan Hydrochloride
Ixabepilone
Gemtuzumab Ozogamicin
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Dacarbazine
Letrozole
Nucleic Acid Sequencing
Ac Regimen
Cytogenetic Analysis
Chemotherapy
Therapeutic Thoracoscopy
Videothoracoscopy
Bleomycin Sulfate
Abvd Regimen
Beacopp Regimen
Procarbazine Hydrochloride
Vinorelbine Ditartrate
Single Photon Emission Computed Tomography
Pixantrone Dimaleate
Placebo Administration
Recombinant Interferon Alfa-2b
Octreotide Acetate
Dinaciclib
Cryopreservation
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
Active Surveillance
